Literature DB >> 1696895

Enhanced immunogenicity of recombinant peptide fusions containing multiple copies of a heterologous T helper epitope.

B Löwenadler1, A M Svennerholm, M Gidlund, E Holmgren, K Krook, C Svanholm, S Ulff, S Josephson.   

Abstract

We have examined the immune response against the nonimmunogenic heat-stable enterotoxin (STa) of enterotoxigenic Escherichia coli using recombinant fusion proteins containing the STa-peptide linked to an IgG-binding analogue of protein A and varying numbers of the T helper epitope 323-339 from ovalbumin (ova). By immunization of inbred strains of mice with a series of STa fusion proteins, containing up to four copies of ova tandemly multiplied, we demonstrated that the anti-STa antibody response is controlled by ova-specific T helper cells in a genetically restricted manner. In the responding mouse strains (2 out of 3 tested), the level of antibody production was increased by addition of multiple ova epitopes, the anti-STa response being considerably higher to fusion proteins containing four than one or two ova epitopes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696895     DOI: 10.1002/eji.1830200720

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

Review 1.  Human cartilage proteoglycans as T cell autoantigens.

Authors:  J A Goodacre; J P Pearson
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

2.  Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax.

Authors:  Jon Oscherwitz; Fen Yu; Jana L Jacobs; Kemp B Cease
Journal:  Clin Vaccine Immunol       Date:  2013-01-02

3.  Immunogenicity of genetically engineered glutathione S-transferase fusion proteins containing a T-cell epitope from diphtheria toxin.

Authors:  S Pillai; K Dermody; B Metcalf
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.